BICX (BioCorRx) Cyclically Adjusted PB Ratio: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BICX BioCorRx Inc BICX
40 GF Score
Price $0.25
GF Value $2.77
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is BioCorRx Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioCorRx  (OTCPK:BICX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioCorRx Cyclically Adjusted PB Ratio Related Terms


BioCorRx Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for BioCorRx's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCorRx Cyclically Adjusted PB Ratio Chart

BioCorRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioCorRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BICX vs HLYK, AMS, BMGL: Cyclically Adjusted PB Ratio Comparison

For the Medical Care Facilities subindustry, BioCorRx's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCorRx Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioCorRx's Cyclically Adjusted PB Ratio falls into.


BICX
40GF Score
BioCorRx Inc BICX
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCorRx Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioCorRx's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, BioCorRx's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.397/330.2130*330.2130
=-0.397

Current CPI (Mar. 2026) = 330.2130.

BioCorRx Quarterly Data

Book Value per Share CPI Adj_Book
201606 -2.741 241.018 -3.755
201609 -4.118 241.428 -5.632
201612 -4.484 241.432 -6.133
201703 -18.385 243.801 -24.901
201706 -0.709 244.955 -0.956
201709 -1.089 246.819 -1.457
201712 -1.604 246.524 -2.149
201803 -1.776 249.554 -2.350
201806 -1.631 251.989 -2.137
201809 -1.916 252.439 -2.506
201812 -2.178 251.233 -2.863
201903 -2.088 254.202 -2.712
201906 -1.012 256.143 -1.305
201909 0.013 256.759 0.017
201912 -0.188 256.974 -0.242
202003 -0.364 258.115 -0.466
202006 -0.486 257.797 -0.623
202009 -0.612 260.280 -0.776
202012 -0.754 260.474 -0.956
202103 -0.513 264.877 -0.640
202106 -0.663 271.696 -0.806
202109 -0.859 274.310 -1.034
202112 -1.025 278.802 -1.214
202203 -0.957 287.504 -1.099
202206 -1.040 296.311 -1.159
202209 -0.931 296.808 -1.036
202212 -1.049 296.797 -1.167
202303 -1.077 301.836 -1.178
202306 -1.010 305.109 -1.093
202309 -1.065 307.789 -1.143
202312 -1.135 306.746 -1.222
202403 -1.210 312.332 -1.279
202406 -1.127 314.175 -1.185
202409 -1.057 315.301 -1.107
202412 -0.913 315.605 -0.955
202503 -0.719 319.799 -0.742
202506 -0.732 322.561 -0.749
202509 -0.669 324.800 -0.680
202512 -0.459 324.054 -0.468
202603 -0.397 330.213 -0.397

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is BioCorRx (BICX) Overvalued in 2026?

Based on GuruFocus' analysis, BioCorRx stock appears to be undervalued. The current stock price of $0.25 is trading 91% below its estimated GF Value™ of $2.77. GuruFocus considers BioCorRx to be Possible Value Trap.

Key valuation signals for BICX:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $2.77 vs. price of $0.25 (91% below fair value)
  • GF Score™: 40/100 with 7 warning signs

No single metric tells the full story. See the BICX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioCorRx Business Description

Address 2390 East Orangewood Avenue, Suite 570, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides addiction treatment solutions, offering an approach to the treatment of substance use and other related disorders. The company makes the Beat Addiction Recovery Program and UnCraveRx Weight Loss Management Program available to healthcare providers to utilize when the healthcare provider determines it is medically appropriate and indicated for their patients. Its products include BICX102 and BICX104. It operates in a single segment.
40GF Score

Get the complete analysis for BICX

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$2.77
GF Value